Last updated on July 2019

Long-term Safety Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS


Brief description of study

The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study.

Clinical Study Identifier: NCT03650114

Find a site near you

Start Over

Novartis Investigative Site

Cullman, AL United States
  Connect »

Novartis Investigative Site

Fullerton, CA United States
  Connect »

Novartis Investigative Site

Boulder, CO United States
  Connect »

Novartis Investigative Site

Colorado Springs, CO United States
  Connect »

Novartis Investigative Site

Fort Collins, CO United States
  Connect »

Novartis Investigative Site

Atlantis, FL United States
  Connect »

Novartis Investigative Site

Bradenton, FL United States
  Connect »

Novartis Investigative Site

Delray Beach, FL United States
  Connect »

Novartis Investigative Site

Oldsmar, FL United States
  Connect »

Novartis Investigative Site

Ormond Beach, FL United States
  Connect »

Novartis Investigative Site

Pompano Beach, FL United States
  Connect »

Novartis Investigative Site

Port Charlotte, FL United States
  Connect »

Novartis Investigative Site

Sarasota, FL United States
  Connect »

Novartis Investigative Site

West Palm Beach, FL United States
  Connect »

Novartis Investigative Site

Savannah, GA United States
  Connect »

Novartis Investigative Site

Suwanee, GA United States
  Connect »

Novartis Investigative Site

Honolulu, HI United States
  Connect »

Novartis Investigative Site

Northbrook, IL United States
  Connect »

Novartis Investigative Site

Indianapolis, IN United States
  Connect »

Novartis Investigative Site

Alexandria, LA United States
  Connect »

Novartis Investigative Site

Baton Rouge, LA United States
  Connect »

Novartis Investigative Site

Wellesley, MA United States
  Connect »

Novartis Investigative Site

Detroit, MI United States
  Connect »

Novartis Investigative Site

Golden Valley, MN United States
  Connect »

Novartis Investigative Site

Chesterfield, MO United States
  Connect »

Novartis Investigative Site

Saint Louis, MO United States
  Connect »

Novartis Investigative Site

Great Falls, MT United States
  Connect »

Novartis Investigative Site

Asheville, NC United States
  Connect »

Novartis Investigative Site

Greensboro, NC United States
  Connect »

Novartis Investigative Site

Raleigh, NC United States
  Connect »

Novartis Investigative Site

Winston-Salem, NC United States
  Connect »

Novartis Investigative Site

Cleveland, OH United States
  Connect »

Novartis Investigative Site

Columbus, OH United States
  Connect »

Novartis Investigative Site

Westerville, OH United States
  Connect »

Novartis Investigative Site

Oklahoma City, OK United States
  Connect »

Novartis Investigative Site

Portland, OR United States
  Connect »

Novartis Investigative Site

Willow Grove, PA United States
  Connect »

Novartis Investigative Site

Spartanburg, SC United States
  Connect »

Novartis Investigative Site

Johnson City, TN United States
  Connect »

Novartis Investigative Site

Knoxville, TN United States
  Connect »

Novartis Investigative Site

El Paso, TX United States
  Connect »

Novartis Investigative Site

Houston, TX United States
  Connect »

Novartis Investigative Site

Lubbock, TX United States
  Connect »

Novartis Investigative Site

Round Rock, TX United States
  Connect »

Novartis Investigative Site

San Antonio, TX United States
  Connect »

Novartis Investigative Site

Sherman, TX United States
  Connect »

Novartis Investigative Site

Salt Lake City, UT United States
  Connect »

Novartis Investigative Site

Virginia Beach, VA United States
  Connect »

Novartis Investigative Site

Kirkland, WA United States
  Connect »

Novartis Investigative Site

Green Bay, WI United States
  Connect »

Novartis Investigative Site

Neuburg an der Donau, Germany
  Connect »

Novartis Investigative Site

Sittard-Geleen, Netherlands
  Connect »

Novartis Investigative Site

Ekaterinburg, Russian Federation
  Connect »

Novartis Investigative Site

Kazan, Russian Federation
  Connect »

Novartis Investigative Site

Krasnoyarsk, Russian Federation
  Connect »

Novartis Investigative Site

Moscow, Russian Federation
  Connect »

Novartis Investigative Site

Novosibirsk, Russian Federation
  Connect »

Novartis Investigative Site

Pozuelo de Alarcon, Spain
  Connect »

Novartis Investigative Site

Castilleja de la cuesta, Spain
  Connect »

Novartis Investigative Site

Maitland, FL United States
  Connect »

Novartis Investigative Site

Overland Park, KS United States
  Connect »

Novartis Investigative Site

New Lambton Heights, Australia
  Connect »

Novartis Investigative Site

Kemerovo, Russian Federation
  Connect »

Novartis Investigative Site

Saint Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

L Hospitalet De Llobregat, Spain
  Connect »

Novartis Investigative Site

Las Vegas, NV United States
  Connect »

Novartis Investigative Site

Charlotte, NC United States
  Connect »

Novartis Investigative Site

Greenfield Park, QC Canada
  Connect »

Novartis Investigative Site

Nizhny Novgorod, Russian Federation
  Connect »

Novartis Investigative Site

St Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Banska Bystrica, Slovakia
  Connect »

Novartis Investigative Site

Sacramento, CA United States
  Connect »

Novartis Investigative Site

Pensacola, FL United States
  Connect »

Novartis Investigative Site

Kansas City, KS United States
  Connect »

Novartis Investigative Site

Cordova, TN United States
  Connect »

Novartis Investigative Site

Milwaukee, WI United States
  Connect »

Novartis Investigative Site

Santa Maria da Feira, Portugal
  Connect »

Novartis Investigative Site

Saint-Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Tyumen, Russian Federation
  Connect »

Novartis Investigative Site

Haseki / Istanbul, Turkey
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.